Departments of Rheumatology and Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
Sorbonne Université, INSERM CRSA, Department of Rheumatology, AP-HP Saint-Antoine Hospital, Paris, France.
Osteoarthritis Cartilage. 2020 Mar;28(3):242-248. doi: 10.1016/j.joca.2020.01.002. Epub 2020 Jan 13.
Over the past year many studies and clinical trials have been published in the osteoarthritis (OA) field. This review is based on systematic literature review covering the period May 1, 2018 to April 19, 2019; the final selection of articles was subjective. Specifically those articles considered to be presenting novel insights and of potential importance for clinical practice, are discussed. Further evidence has emerged that OA is a serious disease with increasing impact worldwide. Our understanding of development of pain in OA has increased. Detailed studies investigating widely used pharmacological treatments have shown the benefits to be limited, whereas the risks seem higher than expected, suggesting further studies and reconsideration of currently used guidelines. Promising new pharmacological treatments have been developed and published, however subsequent studies are warranted. While waiting for new treatment modalities to appear joint replacement is an effective alternative; new data have become available on how long they might last.
在过去的一年中,许多研究和临床试验已在骨关节炎(OA)领域发表。这篇综述基于系统文献综述,涵盖了 2018 年 5 月 1 日至 2019 年 4 月 19 日的文献;最终文章的选择是主观的。具体来说,那些被认为具有新颖见解和对临床实践具有潜在重要性的文章进行了讨论。进一步的证据表明,OA 是一种严重的疾病,在全球范围内的影响日益增加。我们对 OA 疼痛发展的理解有所增加。对广泛使用的药物治疗进行的详细研究表明,其益处有限,而风险似乎高于预期,这表明需要进一步研究和重新考虑当前使用的指南。有前途的新药物治疗已经开发和发表,但随后的研究是必要的。在等待新的治疗方法出现的同时,关节置换是一种有效的替代方法;关于它们能持续多久的新数据已经可用。
Osteoarthritis Cartilage. 2020-3
Med Lett Drugs Ther. 2014-9-1
BMJ. 2012-7-30
Aust Fam Physician. 2008-3
Hosp Pract (1995). 2011-2